Live News EQUITY FLASH L impact Nov 05, 2026, 11:13 AM UTC Rezera Aims to Raise Up to $217 Million in U.S. IPO Drug developer Rezera said it aims to raise up to $217 million in a U.S. IPO. SquawkNews Desk